Oliver Danne

535 total citations
15 papers, 378 citations indexed

About

Oliver Danne is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Oliver Danne has authored 15 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Epidemiology. Recurrent topics in Oliver Danne's work include Acute Myocardial Infarction Research (9 papers), Cardiac Imaging and Diagnostics (8 papers) and Acute Ischemic Stroke Management (3 papers). Oliver Danne is often cited by papers focused on Acute Myocardial Infarction Research (9 papers), Cardiac Imaging and Diagnostics (8 papers) and Acute Ischemic Stroke Management (3 papers). Oliver Danne collaborates with scholars based in Germany, United States and Australia. Oliver Danne's co-authors include Martin Möckel, Ulrich Frei, Christian Müller, Christian Storm, Clemens Mügge, Jessie Shih, Saul A. Datwyler, Christian Mueller, Bingfang Yue and William L. Roberts and has published in prestigious journals such as PLoS ONE, The American Journal of Cardiology and Clinical Chemistry.

In The Last Decade

Oliver Danne

15 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Danne Germany 11 182 102 92 56 51 15 378
Yuichi Tsunoda Japan 12 254 1.4× 45 0.4× 105 1.1× 12 0.2× 44 0.9× 16 455
Ana Lorenzo-Almorós Spain 10 270 1.5× 40 0.4× 177 1.9× 36 0.6× 92 1.8× 10 526
Wilhelm F. Lubbe New Zealand 7 276 1.5× 60 0.6× 114 1.2× 41 0.7× 27 0.5× 10 512
Emel Öztürk Türkiye 12 73 0.4× 123 1.2× 64 0.7× 20 0.4× 84 1.6× 47 462
Noriyuki Sunahara Japan 12 191 1.0× 79 0.8× 147 1.6× 48 0.9× 39 0.8× 28 507
Eva Ringdal Pedersen Norway 8 66 0.4× 33 0.3× 154 1.7× 21 0.4× 88 1.7× 20 330
Pablo I. Altieri Puerto Rico 12 285 1.6× 85 0.8× 85 0.9× 12 0.2× 123 2.4× 50 479
Ivan Stojanović Serbia 13 70 0.4× 56 0.5× 165 1.8× 23 0.4× 79 1.5× 49 429
İbrahim Halil Altıparmak Türkiye 11 129 0.7× 32 0.3× 58 0.6× 14 0.3× 70 1.4× 40 378
Ryo Ogawa Japan 11 66 0.4× 111 1.1× 59 0.6× 44 0.8× 54 1.1× 41 332

Countries citing papers authored by Oliver Danne

Since Specialization
Citations

This map shows the geographic impact of Oliver Danne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Danne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Danne more than expected).

Fields of papers citing papers by Oliver Danne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Danne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Danne. The network helps show where Oliver Danne may publish in the future.

Co-authorship network of co-authors of Oliver Danne

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Danne. A scholar is included among the top collaborators of Oliver Danne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Danne. Oliver Danne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Danne, Oliver. (2018). Trimethylamine N-oxide and ACE inhibitors: fighting a new enemy with an established weapon?. Biomarkers. 23(6). 509–511. 1 indexed citations
2.
Storm, Christian, Oliver Danne, Per Magne Ueland, et al.. (2013). Serial Plasma Choline Measurements after Cardiac Arrest in Patients Undergoing Mild Therapeutic Hypothermia: A Prospective Observational Pilot Trial. PLoS ONE. 8(9). e76720–e76720. 4 indexed citations
3.
Searle, Julia, Jessie Shih, Reinhold Müller, et al.. (2013). The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department. European Heart Journal Acute Cardiovascular Care. 2(3). 203–210. 11 indexed citations
4.
Danne, Oliver & Martin Möckel. (2010). Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Review of Molecular Diagnostics. 10(2). 159–171. 35 indexed citations
5.
Möckel, Martin, Oliver Danne, Reinhold Müller, et al.. (2008). Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clinica Chimica Acta. 393(2). 103–109. 39 indexed citations
6.
Storm, Christian, et al.. (2008). Effect of the Glycoprotein IIb/IIIa Inhibitor Tirofiban on Concentrations of Whole Blood Choline in Acute Coronary Syndromes. Laboratory Medicine. 39(6). 349–355. 2 indexed citations
7.
Shih, Jessie, et al.. (2008). Effect of Collection Tube Type and Preanalytical Handling on Myeloperoxidase Concentrations. Clinical Chemistry. 54(6). 1076–1079. 55 indexed citations
8.
Yue, Bingfang, et al.. (2008). Choline in Whole Blood and Plasma: Sample Preparation and Stability. Clinical Chemistry. 54(3). 590–593. 38 indexed citations
9.
Danne, Oliver, et al.. (2007). Whole blood choline and plasma choline in acute coronary syndromes: Prognostic and pathophysiological implications. Clinica Chimica Acta. 383(1-2). 103–109. 50 indexed citations
10.
Danne, Oliver, et al.. (2007). Evaluation of a Chemiluminescent Assay for Analysis of Choline in Human Plasma and Whole Blood. Laboratory Medicine. 38(12). 726–728. 2 indexed citations
11.
Danne, Oliver, et al.. (2003). Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. The American Journal of Cardiology. 91(9). 1060–1067. 76 indexed citations
12.
Möckel, Martin, W. Gerhardt, Günther Heller, et al.. (2001). Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. Clinica Chimica Acta. 303(1-2). 167–179. 11 indexed citations
13.
Möckel, Martin, Günther Heller, Oliver Danne, et al.. (2000). The acute coronary syndrome diagnosis and prognostic evaluation by troponin I is influenced by the test system affinity to different troponin complexes. Clinica Chimica Acta. 293(1-2). 139–155. 15 indexed citations
14.
Danne, Oliver, et al.. (1995). Left ventricular hypertrophy and diastolic dysfunction: Their relation to coronary heart disease. Cardiovascular Drugs and Therapy. 9(S3). 533–537. 24 indexed citations
15.
Felix, Roland, et al.. (1989). Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA. Cardiovascular Drugs and Therapy. 3(5). 779–788. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026